Impact of the coronavirus disease pandemic on robot‐assisted radical prostatectomy and urologists' treatment behaviors: A single tertiary center retrospective study
International Journal of Urology · 2024
DOI: 10.1111/iju.15479 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Urology, 2024. Verfasst von Yoichiro Tohi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Faculty of Medicine, Kagawa University, Kita-gun, Kagawa, Japan. Hauptthemen laut MEDLINE: Prostatectomy, Robotic Surgical Procedures, COVID-19, Prostatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Objectives
To assess whether the coronavirus disease (COVID‐19) pandemic affected the outcomes of robot‐assisted radical prostatectomy (RARP) and urologists' treatment behaviors.
Methods
We retrospectively examined the medical records of 208 patients who had undergone RARP between August 2017 and December 2022. We compared the rate of preoperative androgen deprivation therapy (ADT), waiting period for RARP, patients' baseline characteristics and quality of life (QOL), proportion of adverse pathology on the RARP specimen, rate of Gleason grade group upgrading from biopsy to the RARP specimen, and prostate‐specific antigen (PSA) recurrence‐free survival between the pre‐pandemic and pandemic groups.
Results
The rate of preoperative ADT was significantly higher during than before the COVID‐19 pandemic (13.7% vs. 1.9%; p = 0.002). The baseline physical and mental QOL scores did not differ significantly between the groups. The proportion of D'Amico low‐risk patients was significantly lower (13.6% vs. 1.2%, p = 0.005) and waiting period for RARP was significantly shorter (median 3.5 months vs. 4.0 months, p = 0.016) in the pandemic group than in the pre‐pandemic group. There was no significant difference in the proportion of adverse pathology between the groups ( p = 0.104); however, the upgrading rate was significantly higher in the pre‐pandemic group ( p = 0.002). There was no significant difference in PSA recurrence‐free survival between the groups (log‐rank, p = 0.752).
Conclusions
The COVID‐19 pandemic did not adversely affect the oncologic outcomes of RARP and QOL before RARP. However, it caused urologists to increase the use of preoperative ADT and to reserve RARP for higher‐risk cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Faculty of Medicine, Kagawa University, Kita-gun, Kagawa, Japan.
ORCID-Profile: Yoichiro Tohi, Rikiya Taoka, Mikio Sugimoto
Zitieren
APA
Tohi, Y., Osaki, Y., Kato, T., Honda, T., Abe, Y., Naito, H., Matsuoka, Y., Okazoe, H., Taoka, R., Ueda, N., & Sugimoto, M. (2024). Impact of the coronavirus disease pandemic on robot‐assisted radical prostatectomy and urologists' treatment behaviors: A single tertiary center retrospective study. International Journal of Urology. https://doi.org/10.1111/iju.15479
Vancouver
Tohi Y, Osaki Y, Kato T, Honda T, Abe Y, Naito H, et al. Impact of the coronavirus disease pandemic on robot‐assisted radical prostatectomy and urologists' treatment behaviors: A single tertiary center retrospective study. International Journal of Urology. 2024. doi:10.1111/iju.15479
BibTeX
@article{Tohi2024,
author = {Tohi, Yoichiro and Osaki, Yu and Kato, Takuma and Honda, Tomoko and Abe, Yohei and Naito, Hirohito and Matsuoka, Yuki and Okazoe, Homare and Taoka, Rikiya and Ueda, Nobufumi and Sugimoto, Mikio},
title = {Impact of the coronavirus disease pandemic on robot‐assisted radical prostatectomy and urologists' treatment behaviors: A single tertiary center retrospective study},
journal = {International Journal of Urology},
year = {2024},
doi = {10.1111/iju.15479}
}
EUVIMED